Physician profile
Amy Licata
NPI 1255393054
$2,832.15
in general payments reported to CMS, 2019-2025
13 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $448 · 2022: $709 · 2023: $835 · 2024: $332 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $855.44 | 2022-2025 | Camzyos, Eliquis |
| Pfizer INC. | $557.61 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $359.77 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $310.53 | 2021-2024 | Brilinta, Farxiga |
| Madrigal Pharmaceuticals | $150.00 | 2025 | Rezdiffra |
| Novartis Pharmaceuticals Corporation | $135.69 | 2021-2023 | |
| Boston Scientific Corporation | $125.00 | 2021 | |
| Lantheus Medical Imaging, INC. | $99.20 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.45 | 2021-2025 | Lifevest |
| Scpharmaceuticals INC. | $61.71 | 2023-2025 | |
| Impulse Dynamics (USA) INC. | $44.78 | 2023 | Optimizer |
| Abbott Laboratories | $25.19 | 2024 | Navitor |
| Eisai INC. | $21.78 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Licata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.